Sign In
Buy MRTX
$58.70
+0 (+0%)
At Close: Apr 19, 2024
Alume Biosciences Completes $5.5M Series A Financing
04:00pm, Friday, 01'st May 2020
Alume Biosciences, Inc., a privately held biotechnology company developing nerve-targeted pharmaceuticals for surgical and therapeutic use, today announced that it has completed a Series A funding in
JPMorgan upgrades Mirati Therapeutics to Overweight on MRTX849 potential MRTX
01:10pm, Friday, 01'st May 2020
JPMorgan upgrades Mirati Therapeutics to Overweight on MRTX849 potential JPMorgan MRTX
Guggenheim likes Seattle Genetics in premarket analyst action
11:42am, Friday, 01'st May 2020
Axcella Health (NASDAQ:AXLA) initiated with Buy rating and $10 (115% upside) price target at BTIG Research.Viking Therapeutics (NASDAQ:VKTX) initiated with Buy rating and $9 (56% upside) price target
U.S. RESEARCH ROUNDUP- Comcast, Mirati Therapeutics, Oceanfirst Financial
10:44am, Friday, 01'st May 2020
Wall Street securities analysts revised their ratings and price targets on several U.S.-listed
companies, including Comcast, Mirati Therapeutics and Oceanfirst Financial, on Friday.
HIGHLIGHTS
Mirati Therapeutics upgraded to Overweight from Neutral at JPMorgan MRTX
09:05am, Friday, 01'st May 2020
Mirati Therapeutics upgraded to Overweight from Neutral at JPMorgan JPMorgan MRTX
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Apellis Pharmaceuticals (APLS)
05:53pm, Thursday, 30'th Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vertex Pharmaceuticals (VRTX) and Apellis Pharmaceuticals (APLS). Vertex
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (NASDAQ: VRTX) and Apellis Pharmaceuticals (NASDAQ: APLS)
05:53pm, Thursday, 30'th Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vertex Pharmaceuticals (
VRTX
–
Research Report
) and Apellis Pharmaceuticals (
APLS
–
Research Report
).
Vertex P
Moss Bros And Victoria's Secret Lost Their Buyers - ValueWalk
03:06pm, Tuesday, 28'th Apr 2020
Both Moss Bros and L Brands’ Victoria’s Secret brand lost their buyers this week, sending both stocks spiralling downwards.
Here's Why Verastem Oncology Is Tanking Today
05:11pm, Monday, 27'th Apr 2020
Details from a clinical trial with the company's latest lead candidate weren't what investors had hoped for.
Analysts Estimate Mirati (MRTX) to Report a Decline in Earnings: What to Look Out for
04:32pm, Monday, 27'th Apr 2020
Mirati (MRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Mirati (MRTX) to Report a Decline in Earnings: What to Look Out for
04:32pm, Monday, 27'th Apr 2020
Mirati (MRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mirati Therapeutics (NASDAQ:MRTX) Stock Rating Lowered by BidaskClub
06:28am, Sunday, 26'th Apr 2020
Mirati Therapeutics (NASDAQ:MRTX) was downgraded by research analysts at BidaskClub from a “buy” rating to a “hold” rating in a research note issued to investors on Friday, BidAskClub reports.
Mirati Therapeutics Sees Unusually Large Options Volume (NASDAQ:MRTX)
05:56am, Saturday, 25'th Apr 2020
Mirati Therapeutics Inc (NASDAQ:MRTX) was the recipient of some unusual options trading on Thursday. Investors bought 2,003 call options on the company. This is an increase of 1,291% compared to the a
Stock Traders Buy Large Volume of Mirati Therapeutics Put Options (NASDAQ:MRTX)
05:22am, Saturday, 25'th Apr 2020
Mirati Therapeutics Inc (NASDAQ:MRTX) saw some unusual options trading activity on Thursday. Investors purchased 2,055 put options on the stock. This is an increase of approximately 2,715% compared to
Mirati Therapeutics (NASDAQ:MRTX) Trading Down 10.2% on Insider Selling
05:14am, Thursday, 23'rd Apr 2020
Mirati Therapeutics Inc (NASDAQ:MRTX)’s stock price was down 10.2% on Tuesday following insider selling activity. The stock traded as low as $85.51 and last traded at $85.62, approximately 1,057,952
